2009
DOI: 10.1007/s12264-009-0107-0
|View full text |Cite
|
Sign up to set email alerts
|

神经细胞中多巴胺d1和d5受体不同亚细胞分布和胞内转运的特性

Abstract: Objective To explore the possible differential trafficking properties of the dopamine D1-like receptor subtypes, D1 receptor and D5 receptor. Methods To visualize distributions of dopamine D1-like receptor subtypes at subcellular level, the yellow and cyan variants of green fluorescent protein (GFP) were used to tag D1 and D5 receptors. After transfection with the tagged dopamine receptors, the neuroblastoma cells NG108-15 were treated with D1 agonist SKF38393 or acetylcholine (ACh). Then we observed the subce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
6
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 39 publications
(63 reference statements)
1
6
0
Order By: Relevance
“…Heydorn et al (18) previously reported that SNX1 interacted with the carboxyl terminus of D 5 R. We confirmed this interaction and further elucidated the distribution of the D 5 R and SNX1 in hPTCs and the human kidney. In hPTCs, D 5 R is found at the plasma membrane and cytoplasm in the basal state, in contrast to the predominantly intracellular expression of D 1 R (38), although D 1 R is localized to the plasma membrane in neuroblastoma cells NG108 -15 (39). On the other hand, SNX1 exists in both membrane and cytoplasmic pools in hPTCs, similar to previous observations in HeLa cells.…”
Section: Discussionsupporting
confidence: 87%
“…Heydorn et al (18) previously reported that SNX1 interacted with the carboxyl terminus of D 5 R. We confirmed this interaction and further elucidated the distribution of the D 5 R and SNX1 in hPTCs and the human kidney. In hPTCs, D 5 R is found at the plasma membrane and cytoplasm in the basal state, in contrast to the predominantly intracellular expression of D 1 R (38), although D 1 R is localized to the plasma membrane in neuroblastoma cells NG108 -15 (39). On the other hand, SNX1 exists in both membrane and cytoplasmic pools in hPTCs, similar to previous observations in HeLa cells.…”
Section: Discussionsupporting
confidence: 87%
“…Our present data is consistent with the hypothesis that decreased D1-Gs coupling results from redistribution of signaling components. A recent study conducted with D 1 and D 5 receptor-expressing cells observed a similar behavior of these two receptors in response to agonist: D 1 receptors translocated from the plasma membrane to intracellular sites while D 5 receptors did not undergo a significant shift when exposed to agonist (He et al, 2009). It is generally understood that excessive or persistent stimulation can induce internalization of G protein-coupled receptors, leading to lysosomal degradation of the receptors or subsequent recycling of the receptors back to the plasma membrane.…”
Section: 0 Discussionmentioning
confidence: 76%
“…Previously published immunohistochemical analyses of D 5 receptors in brain indicated that this receptor was present primarily in the somal cytoplasm in tissues where the receptor was expressed (Ariano et al, 1997; Bergson et al, 1995; Ciliax et al, 2000; Khan et al, 2000; Oda et al). Similarly, in cultured cells D 1 receptors were localized to the plasma membrane, whereas D 5 receptor immunoreactivity was high in the somal cytoplasm and also present on the cell surface (He et al, 2009). The present determination that D 5 receptors do not sediment at 300,000g suggests that these receptors are associated with a microvesicular membrane of high lipid content, rendering it difficult to sediment.…”
Section: 0 Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Considering the temporal profile of their association, it is conceivable that SNX5, D 1 R, and GRK4 may reside in the same membrane microdomain that facilitates the formation of macromolecular signaling complexes, similar to what has been described for other GPCRs that activate adenylyl cyclase (40). D 1 R and GRK4 are present in the plasma membrane (41, 42), where they both reside in lipid rafts (39, 40, 43). SNX5 is partly localized in the lipid rafts, and fenoldopam treatment increases the SNX5 abundance in these rafts (unpublished results).…”
Section: Discussionmentioning
confidence: 99%